A Novel Peptide-Peptoid Hybrid Active Against MRSP Skin Infections

Ines Greco; Peter Panduro Damborg; Luca Guardabassi; Paul Robert Hansen

A Novel Peptide-Peptoid Hybrid Active Against MRSP Skin Infections

Ines Greco, Peter Panduro Damborg, Luca Guardabassi, Paul Robert Hansen

Research output: Contribution to conference › Poster › Research › peer-review

Original language	English
Publication date	4 Nov 2013
Publication status	Published - 4 Nov 2013
Event	3RD ASM-ESCMID CONFERENCE ON METHICILLIN-RESISTANT STAPHYLOCOCCI IN ANIMALS: VETERINARY AND PUBLIC HEALTH IMPLICATIONS - Copenhagen, Denmark Duration: 4 Nov 2013 → 7 Nov 2013

Conference

Conference	3RD ASM-ESCMID CONFERENCE ON METHICILLIN-RESISTANT STAPHYLOCOCCI IN ANIMALS: VETERINARY AND PUBLIC HEALTH IMPLICATIONS
Country/Territory	Denmark
City	Copenhagen
Period	04/11/2013 → 07/11/2013

Cite this

A Novel Peptide-Peptoid Hybrid Active Against MRSP Skin Infections. / Greco, Ines; Damborg, Peter Panduro ; Guardabassi, Luca et al.
2013. Poster session presented at 3RD ASM-ESCMID CONFERENCE ON METHICILLIN-RESISTANT STAPHYLOCOCCI IN ANIMALS: VETERINARY AND PUBLIC HEALTH IMPLICATIONS, Copenhagen, Denmark.

Research output: Contribution to conference › Poster › Research › peer-review

@conference{59d79ed21f944fd3b3f2c0c35ac60b76,

title = "A Novel Peptide-Peptoid Hybrid Active Against MRSP Skin Infections",

author = "Ines Greco and Damborg, {Peter Panduro} and Luca Guardabassi and Hansen, {Paul Robert}",

year = "2013",

month = nov,

day = "4",

language = "English",

note = "3RD ASM-ESCMID CONFERENCE ON METHICILLIN-RESISTANT STAPHYLOCOCCI IN ANIMALS: VETERINARY AND PUBLIC HEALTH IMPLICATIONS ; Conference date: 04-11-2013 Through 07-11-2013",

}

TY - CONF

T1 - A Novel Peptide-Peptoid Hybrid Active Against MRSP Skin Infections

AU - Greco, Ines

AU - Damborg, Peter Panduro

AU - Guardabassi, Luca

AU - Hansen, Paul Robert

PY - 2013/11/4

Y1 - 2013/11/4

M3 - Poster

T2 - 3RD ASM-ESCMID CONFERENCE ON METHICILLIN-RESISTANT STAPHYLOCOCCI IN ANIMALS: VETERINARY AND PUBLIC HEALTH IMPLICATIONS

Y2 - 4 November 2013 through 7 November 2013

ER -